nicardipine has been researched along with Coronary Disease in 72 studies
Nicardipine: A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents.
nicardipine : A racemate comprising equimolar amounts of (R)- and (S)-nicardipine. It is a calcium channel blocker which is used to treat hypertension.
2-[benzyl(methyl)amino]ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate : A dihydropyridine that is 1,4-dihydropyridine substituted by a methyl, {2-[benzyl(methyl)amino]ethoxy}carbonyl, 3-nitrophenyl, methoxycarbonyl and methyl groups at positions 2, 3, 4, 5 and 6, respectively.
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nicardipine treatment has been evaluated in patients with chronic stable effort angina or with angina at rest due to coronary spasm." | 7.76 | Usefulness of nicardipine for angina pectoris. ( Lambert, CR; Pepine, CJ, 1987) |
| "The efficacy of nicardipine and nitroprusside in preventing poststernotomy hypertension was compared in two groups of 45 patients undergoing coronary artery surgery." | 7.67 | The efficacy of nicardipine and nitroprusside in preventing poststernotomy hypertension. ( Deen, L; Dijkhuis, JP; Koolen, JJ; Leyssius, AT; Meyne, NG; van Wezel, HB; Vergroesen, I; Visser, CA, 1989) |
| "To examine whether nicardipine, a dihydropyridine derivative, limits size of myocardial infarction, and to compare the protective effects of nicardipine administered before and early and late after coronary artery occlusion, 99mTc-labeled albumin microspheres were injected into the left atrium during 5 min temporary coronary artery occlusion to determine the extent of the hypoperfused zone (the area at risk)." | 7.67 | Comparative effects of nicardipine, a new calcium antagonist, on size of myocardial infarction after coronary artery occlusion in dogs. ( Endo, T; Fujita, S; Hayakawa, H; Iida, N; Kikuchi, K; Kiuchi, K; Nejima, J; Okumura, H, 1986) |
| "Nicardipine is a potent coronary and systemic vasodilating drug that improves exercise tolerance and myocardial metabolic response to pacing stress, the mechanism for which appears to be partially mediated through increased coronary blood flow." | 5.27 | Effects of nicardipine on exercise- and pacing-induced myocardial ischemia in angina pectoris. ( Feldman, RL; Hill, JA; Lambert, CR; Pepine, CJ, 1987) |
| "We assessed the efficacy of a continuous infusion of nicardipine and nitroglycerin in reducing the incidence and severity of perioperative myocardial ischemia during elective coronary artery bypass grafting procedures in a prospective, randomized, controlled study." | 5.09 | Antiischemic effects of nicardipine and nitroglycerin after coronary artery bypass grafting. ( Apostolidou, IA; Despotis, GJ; Hauptmann, EL; Hogue, CW; Lappas, DG; McCawley, CA; Skubas, NJ, 1999) |
| "The new calcium antagonist nicardipine (barizine) was tested for effects on platelet function and transient myocardial ischemia in 23 patients with coronary heart disease." | 5.07 | [Characteristics of nicardipine treatment of patients with ischemic heart disease]. ( Barinov, VG; Galichenko, IV; Makarovskiĭ, VV; Martynov, AI; Styrova, TK; Vertkin, AL; Zharov, EI, 1991) |
| "Altogether 12 patients with stable angina pectoris of effort were examined for the efficacy of nicardipine as compared to nifedipine and placebo by means of pharmacodynamic studies using treadmill." | 5.06 | [The comparative efficacy of nicardipine and nifedipine in stenocardia patients]. ( Martsevich, SIu; Metelitsa, VI; Simkhaev, LS; Slastnikova, ID, 1990) |
| "The efficacy of nicardipine vs nitroprusside in controlling hypertension after sternotomy was compared in 120 patients undergoing coronary artery bypass grafting and anesthetized with fentanyl (100 micrograms/kg)." | 5.06 | Antihypertensive and anti-ischemic effects of nicardipine and nitroprusside in patients undergoing coronary artery bypass grafting. ( Deen, L; Dijkhuis, JP; Koolen, JJ; Moulijn, AC; van Wezel, HB; Vergroesen, I; Visser, CA, 1989) |
| "We have used a modified noninvasive echo-Doppler cardiac output device, based on the principle of attenuated compensation volume flow, to assess the cardiovascular effects of the slow-calcium antagonist nicardipine in coronary disease." | 5.06 | Hemodynamic assessment of nicardipine alone and with atenolol in coronary artery disease using a modified echo-Doppler device. ( Silke, B; Taylor, SH; Verma, SP; Zezulka, AV, 1989) |
| "Nicardipine treatment has been evaluated in patients with chronic stable effort angina or with angina at rest due to coronary spasm." | 3.76 | Usefulness of nicardipine for angina pectoris. ( Lambert, CR; Pepine, CJ, 1987) |
| "Hepatic function was studied in 31 patients with coronary heart disease before and after treatment with nicardipine." | 3.68 | [Effects of nicardipine on the functional state of the liver in patients with ischemic heart disease]. ( Makarovskiĭ, VV; Makeeva, LG; Martynov, AI; Shafranskiĭ, IuA; Svetova, SD; Vertkin, AL, 1991) |
| "To assess the effect of nicardipine on left ventricular (LV) diastolic function independent of concurrent effects on loading conditions in patients with LV systolic dysfunction due to coronary artery disease, equihypotensive doses of intravenous nitroprusside and nicardipine were administered to 12 patients with congestive heart failure due to previous myocardial infarction (LV ejection fraction less than 0." | 3.68 | Left ventricular diastolic function in patients with left ventricular systolic dysfunction due to coronary artery disease and effect of nicardipine. ( Aroney, CN; Boucher, CA; Dec, GW; Fifer, MA; Semigran, MJ, 1991) |
| "The efficacy of nicardipine and nitroprusside in preventing poststernotomy hypertension was compared in two groups of 45 patients undergoing coronary artery surgery." | 3.67 | The efficacy of nicardipine and nitroprusside in preventing poststernotomy hypertension. ( Deen, L; Dijkhuis, JP; Koolen, JJ; Leyssius, AT; Meyne, NG; van Wezel, HB; Vergroesen, I; Visser, CA, 1989) |
| "Pharmacokinetic, haemodynamic and radionuclide studies explored the acute pharmacokinetic and pharmacodynamic actions of nicardipine in patients with coronary heart disease." | 3.67 | Pharmacokinetic, haemodynamic and radionuclide studies with nicardipine in coronary artery disease. ( Finlayson, JR; Frais, MA; Graham, DJ; Reynolds, G; Silke, B; Taylor, SH; Verma, SP, 1986) |
| "To examine whether nicardipine, a dihydropyridine derivative, limits size of myocardial infarction, and to compare the protective effects of nicardipine administered before and early and late after coronary artery occlusion, 99mTc-labeled albumin microspheres were injected into the left atrium during 5 min temporary coronary artery occlusion to determine the extent of the hypoperfused zone (the area at risk)." | 3.67 | Comparative effects of nicardipine, a new calcium antagonist, on size of myocardial infarction after coronary artery occlusion in dogs. ( Endo, T; Fujita, S; Hayakawa, H; Iida, N; Kikuchi, K; Kiuchi, K; Nejima, J; Okumura, H, 1986) |
| "Orthostatic hypotension is a dangerous problem in elderly patients, often exacerbated by vasodilator medications." | 2.68 | Cardiovascular adaptation to orthostatic stress during vasodilator therapy. ( Abernethy, D; Connelly, CM; Kelley-Gagnon, M; Kiely, DK; Lipsitz, LA; Waksmonski, C, 1996) |
| " After a stable control period, dose-response curves were constructed for each drug with hemodynamics measured 10 minutes after intravenous boluses." | 2.66 | Comparative hemodynamic dose-response effects of five slow calcium channel-blocking agents in coronary artery disease. ( Frais, MA; Jackson, N; Midtbo, KA; Reynolds, G; Sharma, S; Silke, B; Taylor, SH; Verma, SP, 1987) |
| "Nicardipine or saline was randomly infused during the first or second pacing." | 2.66 | Effects of intracoronary infusion of nicardipine during silent ischaemia on myocardial metabolism and function. ( Caucheteux, D; Gurné, O; Hanet, C; Hue, L; Pouleur, H; Rousseau, MF, 1988) |
| "Nicardipine has high affinity for the dihydropyridine-binding site and has been shown to inhibit the influx of extracellular calcium through membrane slow channels." | 2.37 | Animal pharmacology of nicardipine and its clinical relevance. ( Whiting, RL, 1987) |
| "Nicardipine is a powerful systemic vasodilator with minimal effects on myocardial inotropic state, even in patients with compromised left ventricular function and patients receiving beta blocker therapy." | 2.37 | Hemodynamics of nicardipine in coronary artery disease. ( Dunning, AJ; Koolen, JJ; van Wezel, H; Visser, CA, 1987) |
| "Nicardipine was administered as a 2 mg bolus followed by an infusion, titrated to maintain a 10 to 20 mm Hg decrease in systolic arterial pressure." | 1.28 | Acute antianginal hemodynamic effects of nicardipine in coronary artery disease. ( Lambert, CR; Pepine, CJ, 1990) |
| "Nicardipine-based treatment is therefore effective, safe, and well tolerated in elderly hypertensive patients with concomitant disease." | 1.28 | The clinical performance of nicardipine in elderly hypertensive patients with concomitant diseases. ( Leonetti, G, 1989) |
| "Nicardipine is a powerful arteriodilator without detectable negative inotropic effects and prolongs the time to pacing induced angina." | 1.27 | Effect of nicardipine on left ventricular function and on angina induced by atrial pacing in patients with coronary artery disease. ( Lipkin, DP; Poole-Wilson, PA, 1985) |
| "Nicardipine is a potent coronary and systemic vasodilating drug that improves exercise tolerance and myocardial metabolic response to pacing stress, the mechanism for which appears to be partially mediated through increased coronary blood flow." | 1.27 | Effects of nicardipine on exercise- and pacing-induced myocardial ischemia in angina pectoris. ( Feldman, RL; Hill, JA; Lambert, CR; Pepine, CJ, 1987) |
| "Nicardipine was administered as a 2 mg bolus (i." | 1.27 | Effects of nicardipine on left ventricular function and energetics in man. ( Feldman, RL; Hill, JA; Lambert, CR; Pepine, CJ, 1986) |
| "When nicardipine (0." | 1.27 | Effects of nicardipine on ischemic mechanical failure and tissue injury in isolated perfused rat heart. ( Noshiro, O; Ohhata, I; Ohta, A; Shikama, H, 1985) |
| "The haemodynamic dose-response effects of the slow channel blocking agent nicardipine were evaluated in 10 male patients with angiographically confirmed coronary artery disease." | 1.27 | Haemodynamic dose-response effects of i.v. nicardipine in coronary artery disease. ( Hussain, M; Nelson, GI; Silke, B; Taylor, SH; Verma, SP, 1984) |
| "Nicardipine is a potent vasodilator, which produced a marked reduction of systemic vascular resistance and left ventricular end-diastolic pressure during exercise." | 1.27 | Immediate and longer-term effects of nicardipine, at rest and during exercise, in patients with coronary artery disease. ( Jaarsma, W; Kan, G; Lie, KI; Visser, CA, 1984) |
| "nicardipine was given to 9 patients with coronary artery disease, pretreated with propranolol (0." | 1.27 | Effects of nicardipine or nifedipine added to propranolol in patients with coronary artery disease. ( Brasseur, LA; Charlier, AA; Etienne, J; Pouleur, H; Rousseau, MF; Van Eyll, C; Van Mechelen, H, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 47 (65.28) | 18.7374 |
| 1990's | 21 (29.17) | 18.2507 |
| 2000's | 4 (5.56) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Casthely, PA | 2 |
| Bunik, T | 1 |
| Yoganathan, T | 1 |
| Komer, C | 1 |
| Mekhjian, H | 1 |
| Silke, B | 6 |
| Verma, SP | 6 |
| Nelson, GI | 1 |
| Hussain, M | 1 |
| Taylor, SH | 6 |
| Lipkin, D | 1 |
| Poole-Wilson, PA | 2 |
| Visser, CA | 5 |
| Jaarsma, W | 2 |
| Kan, G | 2 |
| Lie, KI | 2 |
| Pouleur, H | 5 |
| Etienne, J | 1 |
| Van Mechelen, H | 1 |
| Van Eyll, C | 3 |
| Charlier, AA | 3 |
| Brasseur, LA | 1 |
| Rousseau, MF | 5 |
| Sunamori, M | 1 |
| Okamura, T | 1 |
| Amano, J | 1 |
| Suzuki, A | 1 |
| Hopf, R | 1 |
| Becker, HJ | 1 |
| Kober, G | 1 |
| Dowinsky, S | 1 |
| Kaltenbach, M | 1 |
| Nakaya, H | 1 |
| Kanno, M | 1 |
| Kaufmann, P | 1 |
| Vassalli, G | 1 |
| Utzinger, U | 1 |
| Hess, OM | 1 |
| Lam, JY | 1 |
| Latour, JG | 1 |
| Lespérance, J | 2 |
| Waters, D | 2 |
| Nomura, M | 1 |
| Miura, Y | 1 |
| Uchida, K | 1 |
| Nagasawa, C | 1 |
| Takahashi, K | 1 |
| Kawai, N | 1 |
| Nomura, Y | 1 |
| Fujita, M | 1 |
| Suzuki, H | 1 |
| Lambert, CR | 9 |
| Grady, T | 1 |
| Hashimi, W | 1 |
| Blakely, M | 1 |
| Panayioutou, H | 1 |
| Lipsitz, LA | 1 |
| Connelly, CM | 1 |
| Kelley-Gagnon, M | 1 |
| Kiely, DK | 1 |
| Abernethy, D | 1 |
| Waksmonski, C | 1 |
| Apostolidou, IA | 1 |
| Despotis, GJ | 1 |
| Hogue, CW | 1 |
| Skubas, NJ | 1 |
| McCawley, CA | 1 |
| Hauptmann, EL | 1 |
| Lappas, DG | 1 |
| Fugit, MD | 1 |
| Rubal, BJ | 1 |
| Donovan, DJ | 1 |
| Williams, MJ | 1 |
| Low, CJ | 1 |
| Wilkins, GT | 1 |
| Stewart, RA | 1 |
| Chanda, J | 1 |
| Canver, CC | 1 |
| Engberding, R | 1 |
| Reinbach, R | 1 |
| Frommelt, T | 1 |
| Zezulka, AV | 2 |
| Sharma, S | 2 |
| Goldhammer, E | 1 |
| Jackson, N | 3 |
| Makeeva, LG | 1 |
| Svetova, SD | 1 |
| Martynov, AI | 3 |
| Vertkin, AL | 3 |
| Makarovskiĭ, VV | 2 |
| Shafranskiĭ, IuA | 1 |
| Timour, Q | 1 |
| Larbre, JP | 1 |
| Aupetit, JF | 1 |
| Gerentes-Chassagne, I | 1 |
| Loufoua-Moundanga, J | 1 |
| Kioueh, I | 1 |
| Faucon, G | 1 |
| Tamburino, C | 1 |
| Russo, G | 1 |
| Di Paola, R | 1 |
| Passaniti, A | 1 |
| Zisa, MB | 1 |
| Felis, S | 1 |
| Calvi, V | 1 |
| Alì, A | 1 |
| Cinnirella, C | 1 |
| Giuffrida, G | 1 |
| Zharov, EI | 2 |
| Styrova, TK | 2 |
| Galichenko, IV | 2 |
| Barinov, VG | 1 |
| Hano, O | 1 |
| Silverman, HS | 1 |
| Blank, PS | 1 |
| Mellits, ED | 1 |
| Baumgardner, R | 1 |
| Lakatta, EG | 1 |
| Stern, MD | 1 |
| Aroney, CN | 1 |
| Semigran, MJ | 1 |
| Dec, GW | 1 |
| Boucher, CA | 1 |
| Fifer, MA | 1 |
| Sedov, VP | 1 |
| Rocha, P | 2 |
| Guerret, M | 1 |
| David, D | 2 |
| Marchand, X | 1 |
| Kahn, JC | 2 |
| Slastnikova, ID | 1 |
| Martsevich, SIu | 1 |
| Simkhaev, LS | 1 |
| Metelitsa, VI | 1 |
| Markham, A | 1 |
| Morgan, RM | 1 |
| Sweetman, AJ | 1 |
| Pepine, CJ | 8 |
| Tachibana, H | 1 |
| Whiting, RL | 1 |
| Feldman, RL | 5 |
| MacDonald, RG | 1 |
| Hill, JA | 5 |
| Horiuchi, K | 1 |
| van Wezel, HB | 2 |
| Koolen, JJ | 4 |
| Vergroesen, I | 2 |
| Leyssius, AT | 1 |
| Dijkhuis, JP | 2 |
| Meyne, NG | 1 |
| Deen, L | 2 |
| Zadionchenko, VS | 1 |
| Kamenker, ES | 1 |
| Chikvashvili, IA | 1 |
| Baba, A | 1 |
| Arita, M | 1 |
| Masuyama, Y | 1 |
| Moulijn, AC | 1 |
| McCarthy, G | 1 |
| Kenny, D | 1 |
| Lipkin, DP | 1 |
| Leonetti, G | 1 |
| Di Biase, M | 1 |
| Massari, V | 1 |
| Amodio, G | 1 |
| Favale, S | 1 |
| Rizzon, P | 1 |
| Hanet, C | 3 |
| Vincent, MF | 1 |
| Lavenne-Pardonge, E | 1 |
| Bélichard, P | 1 |
| Pruneau, D | 1 |
| Rochette, L | 1 |
| Frais, MA | 3 |
| Midtbo, KA | 1 |
| Reynolds, G | 3 |
| Custro, N | 1 |
| Scafidi, V | 1 |
| Berland, J | 1 |
| Savin, T | 1 |
| Saoudi, N | 1 |
| Cribier, A | 1 |
| Letac, B | 1 |
| Prida, XE | 1 |
| Gurné, O | 2 |
| Hue, L | 1 |
| Caucheteux, D | 1 |
| Rodrigues, EA | 2 |
| Kohli, RS | 1 |
| Hains, AD | 1 |
| Lahiri, A | 2 |
| Raftery, EB | 2 |
| van Wezel, H | 1 |
| Dunning, AJ | 1 |
| Thomassen, AR | 1 |
| Bagger, JP | 1 |
| Nielsen, TT | 1 |
| Miyamori, R | 1 |
| Nakamura, Y | 1 |
| Mori, H | 1 |
| Miyazaki, T | 1 |
| Kojima, S | 1 |
| Abe, S | 1 |
| Takahashi, M | 1 |
| Hattori, S | 1 |
| Imai, H | 1 |
| Matsui, K | 1 |
| Ochi, S | 1 |
| Nakazawa, M | 1 |
| Nakagawa, Y | 1 |
| Imai, S | 1 |
| Freedman, D | 1 |
| Theroux, P | 1 |
| Lemarbre, L | 1 |
| Kamm, B | 1 |
| Joyal, M | 1 |
| Dyrda, I | 1 |
| Gosselin, G | 1 |
| Hudon, G | 1 |
| Graham, DJ | 1 |
| Finlayson, JR | 1 |
| Endo, T | 1 |
| Nejima, J | 1 |
| Fujita, S | 1 |
| Kiuchi, K | 1 |
| Iida, N | 1 |
| Kikuchi, K | 1 |
| Hayakawa, H | 1 |
| Okumura, H | 1 |
| Bongrani, S | 1 |
| Schiantarelli, P | 1 |
| Acerbi, D | 1 |
| Ciampalini, G | 1 |
| Ferrari, R | 1 |
| Zannier, D | 1 |
| Baron, B | 1 |
| Pathe, M | 1 |
| Shikama, H | 1 |
| Noshiro, O | 1 |
| Ohta, A | 1 |
| Ohhata, I | 1 |
6 reviews available for nicardipine and Coronary Disease
| Article | Year |
|---|---|
[Treatment of angina pectoris with calcium antagonists].
Topics: Angina Pectoris; Calcium Channel Blockers; Coronary Disease; Diltiazem; Drug Therapy, Combination; E | 1982 |
Cardiovascular effects of nicardipine.
Topics: Animals; Arrhythmias, Cardiac; Cardiovascular System; Coronary Disease; Heart; Heart Failure; Hemody | 1990 |
Animal pharmacology of nicardipine and its clinical relevance.
Topics: Action Potentials; Animals; Calcium; Coronary Disease; Dose-Response Relationship, Drug; Drug Evalua | 1987 |
Effects of nicardipine on coronary blood flow.
Topics: Animals; Coronary Circulation; Coronary Disease; Coronary Vessels; Hemodynamics; Humans; Muscle, Smo | 1988 |
Usefulness of nicardipine for angina pectoris.
Topics: Angina Pectoris; Clinical Trials as Topic; Coronary Disease; Heart; Humans; Myocardium; Nicardipine; | 1987 |
Hemodynamics of nicardipine in coronary artery disease.
Topics: Coronary Disease; Coronary Vessels; Dose-Response Relationship, Drug; Drug Evaluation; Hemodynamics; | 1987 |
22 trials available for nicardipine and Coronary Disease
| Article | Year |
|---|---|
Nicardipine or nitroglycerin in patients with failed percutaneous coronary angioplasty: effect on myocardial diastolic function.
Topics: Adult; Angioplasty, Balloon, Coronary; Biomarkers; Blood Flow Velocity; Calcium Channel Blockers; Co | 2003 |
Effect of nicardipine on myocardial contractility and on angina induced by atrial pacing in patients with coronary artery disease (abstract).
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Cardiac Pacing, Artificial; | 1984 |
Platelet aggregation, coronary artery disease progression and future coronary events.
Topics: 6-Ketoprostaglandin F1 alpha; beta-Thromboglobulin; Coronary Angiography; Coronary Disease; Double-B | 1994 |
Hemodynamic and angiographic comparison of intravenous nitroglycerin and nicardipine mainly in subjects without coronary artery disease.
Topics: Adult; Aged; Cardiac Catheterization; Chest Pain; Coronary Angiography; Coronary Circulation; Corona | 1993 |
Cardiovascular adaptation to orthostatic stress during vasodilator therapy.
Topics: Aged; Aged, 80 and over; Coronary Disease; Cross-Over Studies; Double-Blind Method; Echocardiography | 1996 |
Antiischemic effects of nicardipine and nitroglycerin after coronary artery bypass grafting.
Topics: Aged; Coronary Artery Bypass; Coronary Disease; Dose-Response Relationship, Drug; Electrocardiograph | 1999 |
Effects of intracoronary nicardipine, diltiazem and verapamil on coronary blood flow.
Topics: Aged; Calcium Channel Blockers; Coronary Circulation; Coronary Disease; Coronary Vessels; Diltiazem; | 2000 |
Randomised comparison of the effects of nicardipine and esmolol on coronary artery wall stress: implications for the risk of plaque rupture.
Topics: Adrenergic beta-Antagonists; Aged; Blood Pressure; Calcium Channel Blockers; Coronary Angiography; C | 2000 |
How does posture influence the haemodynamic assessment of a cardiovascular drug? Experience with nicardipine.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Cardiac Output; Cardiovascular Agents; Coronary Diseas | 1990 |
[Characteristics of nicardipine treatment of patients with ischemic heart disease].
Topics: Adult; Coronary Disease; Humans; Male; Middle Aged; Nicardipine; Platelet Aggregation; Platelet Aggr | 1991 |
[The comparative efficacy of nicardipine and nifedipine in stenocardia patients].
Topics: Angina Pectoris; Chronic Disease; Coronary Disease; Electrocardiography; Exercise Test; Humans; Male | 1990 |
Antihypertensive and anti-ischemic effects of nicardipine and nitroprusside in patients undergoing coronary artery bypass grafting.
Topics: Aged; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease; Electrocardiography; Fenta | 1989 |
Hemodynamic assessment of nicardipine alone and with atenolol in coronary artery disease using a modified echo-Doppler device.
Topics: Adult; Aged; Atenolol; Coronary Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination | 1989 |
Myocardial protection by intracoronary nicardipine administration during percutaneous transluminal coronary angioplasty.
Topics: Angina Pectoris; Angioplasty, Balloon; Coronary Disease; Coronary Vessels; Epoprostenol; Humans; Hyp | 1987 |
Comparative hemodynamic dose-response effects of five slow calcium channel-blocking agents in coronary artery disease.
Topics: Amlodipine; Calcium Channel Blockers; Clinical Trials as Topic; Coronary Disease; Diltiazem; Dose-Re | 1987 |
[Effects of chronic administration of several calcium antagonists on pituitary release of TSH].
Topics: Adult; Atenolol; Calcium Channel Blockers; Clinical Trials as Topic; Coronary Disease; Humans; Hyper | 1987 |
Effects of intracoronary infusion of nicardipine during silent ischaemia on myocardial metabolism and function.
Topics: Adult; Aged; Angina Pectoris; Cardiac Catheterization; Coronary Disease; Glutamine; Heart; Hemodynam | 1988 |
Comparison of nicardipine and verapamil in the management of chronic stable angina.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Coronary Disease; Double-Bli | 1988 |
Usefulness of nicardipine for angina pectoris.
Topics: Angina Pectoris; Clinical Trials as Topic; Coronary Disease; Heart; Humans; Myocardium; Nicardipine; | 1987 |
Improvement in left ventricular diastolic function in patients with stable angina after chronic treatment with verapamil and nicardipine.
Topics: Adult; Aged; Angina Pectoris; Coronary Disease; Diastole; Double-Blind Method; Female; Heart Functio | 1987 |
Design features of a controlled clinical trial to assess the effect of a calcium entry blocker upon the progression of coronary artery disease.
Topics: Adult; Aged; Angiocardiography; Clinical Trials as Topic; Coronary Artery Disease; Coronary Disease; | 1987 |
Haemodynamic analysis of the effects of nicardipine and metoprolol alone and in combination in coronary artery disease.
Topics: Adult; Angina Pectoris; Calcium Channel Blockers; Coronary Disease; Drug Therapy, Combination; Femal | 1985 |
45 other studies available for nicardipine and Coronary Disease
| Article | Year |
|---|---|
Haemodynamic dose-response effects of i.v. nicardipine in coronary artery disease.
Topics: Adult; Calcium Channel Blockers; Coronary Disease; Dose-Response Relationship, Drug; Heart; Hemodyna | 1984 |
Immediate and longer-term effects of nicardipine, at rest and during exercise, in patients with coronary artery disease.
Topics: Aged; Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Cardiac Output; Coronary Disease; F | 1984 |
Effects of nicardipine or nifedipine added to propranolol in patients with coronary artery disease.
Topics: Adult; Aged; Blood Pressure; Calcium Channel Blockers; Coronary Disease; Drug Therapy, Combination; | 1984 |
[Protective effect of nicardipine hydrochloride on the perfused ischemic canine myocardium].
Topics: Animals; Calcium Channel Blockers; Coronary Circulation; Coronary Disease; Dogs; Hemodynamics; Myoca | 1983 |
Assessment of regional left ventricular relaxation in patients with coronary artery disease: importance of geometric factors and changes in wall thickness.
Topics: Adult; Aged; Coronary Disease; Heart Ventricles; Humans; Middle Aged; Muscle Relaxation; Nicardipine | 1984 |
Effects of nicardipine, a new dihydropyridine vasodilator, on coronary circulation and ischemia-induced conduction delay in dogs.
Topics: Animals; Blood Pressure; Coronary Circulation; Coronary Disease; Dogs; Electrophysiology; Female; He | 1982 |
Coronary vasomotion during dynamic exercise: influence of intravenous and intracoronary nicardipine.
Topics: Aged; Analysis of Variance; Cardiac Catheterization; Coronary Angiography; Coronary Disease; Coronar | 1995 |
[Effects on hemodynamics and myocardial metabolism of nicardipine and nitroglycerin during aortic cross clamp in dogs with experimentally produced coronary stenosis].
Topics: Animals; Aorta; Constriction; Coronary Circulation; Coronary Disease; Dogs; Hemodynamics; Lactates; | 1994 |
Reversal of preexisting vasospasm in coronary artery conduits.
Topics: Arteries; Calcium Channel Blockers; Coronary Artery Bypass; Coronary Disease; Culture Techniques; Di | 2001 |
The influence of nicardipine on left ventricular hemodynamics and compliance in patients with coronary heart disease.
Topics: Aged; Case-Control Studies; Coronary Disease; Female; Hemodynamics; Humans; Male; Middle Aged; Nicar | 1990 |
[Effects of nicardipine on the functional state of the liver in patients with ischemic heart disease].
Topics: Adult; Coronary Disease; Humans; Liver; Liver Function Tests; Middle Aged; Nicardipine | 1991 |
Protection against ischaemic ventricular fibrillation by blocking agents of myocardial cell calcium influx. Electrophysiological study in the pig in situ heart.
Topics: Animals; Calcium; Calcium Channel Blockers; Coronary Disease; Diltiazem; Electrophysiology; Myocardi | 1991 |
[Bolus nicardipine in the hemodynamic assessment for heart transplantation of patients with severe failure of ischemic origin and high pulmonary resistance].
Topics: Adult; Cardiac Catheterization; Coronary Angiography; Coronary Disease; Female; Heart Failure; Heart | 1991 |
Nicardipine prevents calcium loading and "oxygen paradox" in anoxic single rat myocytes by a mechanism independent of calcium channel blockade.
Topics: Animals; Calcium; Cell Survival; Coronary Disease; Dose-Response Relationship, Drug; Hypoxia; In Vit | 1991 |
Left ventricular diastolic function in patients with left ventricular systolic dysfunction due to coronary artery disease and effect of nicardipine.
Topics: Atrial Function, Right; Blood Pressure; Cardiac Output; Coronary Disease; Diastole; Female; Gated Bl | 1991 |
[Effects of nicardipine in silent myocardial ischemia].
Topics: Adult; Angina Pectoris; Coronary Disease; Drug Evaluation; Electrocardiography; Heart; Humans; Male; | 1991 |
Kinetics and hemodynamic effects of intravenous nicardipine modified by previous propranolol oral treatment.
Topics: Administration, Oral; Adult; Catheterization, Swan-Ganz; Coronary Disease; Drug Interactions; Hemody | 1990 |
Determination of the extent of ischemic damage and the effect of the calcium antagonist, verapamil following coronary artery ligation in the rat.
Topics: Animals; Calcium; Constriction; Coronary Disease; Creatine Kinase; L-Lactate Dehydrogenase; Male; My | 1990 |
Acute antianginal hemodynamic effects of nicardipine in coronary artery disease.
Topics: Aged; Angina Pectoris; Cardiac Pacing, Artificial; Coronary Disease; Exercise; Hemodynamics; Humans; | 1990 |
[Functional and metabolic effects of nicardipine on ischemic rat hearts with multidose potassium cardioplegia].
Topics: Animals; Cardioplegic Solutions; Coronary Disease; Heart; Heart Arrest, Induced; In Vitro Techniques | 1990 |
Effect of nicardipine on determinants of myocardial ischemia occurring during acute coronary occlusion produced by percutaneous transluminal coronary angioplasty.
Topics: Aged; Angioplasty, Balloon; Collateral Circulation; Coronary Circulation; Coronary Disease; Electroc | 1987 |
[Improvement of ischemic tolerance during percutaneous transluminal coronary angioplasty (PTCA) by nicardipine and trinitroglyceride (TNG)].
Topics: Angioplasty, Balloon, Coronary; Coronary Disease; Electrocardiography; Hemodynamics; Humans; Lactate | 1989 |
The efficacy of nicardipine and nitroprusside in preventing poststernotomy hypertension.
Topics: Blood Pressure; Cardiac Output; Coronary Artery Bypass; Coronary Disease; Heart Rate; Humans; Hypert | 1989 |
[Changes in the platelet-vascular system of hemostasis in patients with ischemic heart disease and hypertension after the treatment].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Blood Coagulation; Calcium Channel Blockers; Cor | 1989 |
[New approach to the development of Ca antagonists].
Topics: Animals; Arrhythmias, Cardiac; Calcium Channel Blockers; Coronary Disease; Humans; Hypertension; Nic | 1989 |
Nicardipine in systemic sclerosis.
Topics: Coronary Circulation; Coronary Disease; Humans; Nicardipine; Scleroderma, Systemic | 1989 |
Effect of nicardipine on left ventricular function and on angina induced by atrial pacing in patients with coronary artery disease.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Calcium Channel Blockers; Cardiac Pacing, | 1985 |
The clinical performance of nicardipine in elderly hypertensive patients with concomitant diseases.
Topics: Aged; Arterial Occlusive Diseases; Blood Pressure; Coronary Disease; Diabetes Complications; Humans; | 1989 |
Electrophysiologic evaluation of intravenous nicardipine in man.
Topics: Blood Pressure; Bundle of His; Cardiomyopathy, Hypertrophic; Coronary Disease; Electrocardiography; | 1989 |
[Arterial hypertension, myocardial hypertrophy and disorders of cardiac rhythm induced by ligation of the left coronary artery in the rat].
Topics: Animals; Cardiomegaly; Coronary Disease; Coronary Vessels; Hypertension; Ligation; Male; Nicardipine | 1987 |
[Systemic and coronary hemodynamic effects of intravenous nicardipine at rest and in ischemia induced by rapid atrial stimulation].
Topics: Adult; Angina Pectoris; Cardiac Pacing, Artificial; Coronary Circulation; Coronary Disease; Female; | 1987 |
Systemic and coronary hemodynamics of labetalol in normotensive patients with ischemic heart disease.
Topics: Coronary Circulation; Coronary Disease; Diltiazem; Hemodynamics; Humans; Labetalol; Nicardipine | 1988 |
Hemodynamic and cardiac metabolic changes during nicardipine-induced myocardial ischemia.
Topics: Angina Pectoris; Coronary Disease; Electrocardiography; Exercise Test; Hemodynamics; Humans; Male; M | 1988 |
Beneficial effects of intracoronary nicardipine on hypoxic myocardium.
Topics: Adenine Nucleotides; Animals; Coronary Disease; Coronary Vessels; Dogs; Energy Metabolism; Infusions | 1987 |
Effects of the new dihydropyridine derivative 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid methyl 6-(5-phenyl-3-pyrazolyloxy)hexyl ester on the cardiohemodynamics and the energy metabolism of ischemic myocardium.
Topics: Animals; Blood Pressure; Calcium Channel Blockers; Chemical Phenomena; Chemistry; Coronary Circulati | 1987 |
Effects of nicardipine on exercise- and pacing-induced myocardial ischemia in angina pectoris.
Topics: Angina Pectoris; Cardiac Catheterization; Cardiac Pacing, Artificial; Coronary Circulation; Coronary | 1987 |
Pharmacokinetic, haemodynamic and radionuclide studies with nicardipine in coronary artery disease.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Cardiac Output; Coronary Disease; Heart Rate; Hemodyna | 1986 |
Comparative effects of nicardipine, a new calcium antagonist, on size of myocardial infarction after coronary artery occlusion in dogs.
Topics: Animals; Arrhythmias, Cardiac; Coronary Circulation; Coronary Disease; Dogs; Female; Hemodynamics; M | 1986 |
[Protective effect of nicardipine in an experimental model of transient myocardial ischemia in anesthetized dogs].
Topics: Animals; Coronary Disease; Dogs; Electrocardiography; Female; Hemodynamics; Lactates; Lactic Acid; M | 1986 |
Impaired regional diastolic distensibility in coronary artery disease: relations with dynamic left ventricular compliance.
Topics: Adult; Angina Pectoris; Coronary Circulation; Coronary Disease; Humans; Middle Aged; Myocardial Cont | 1986 |
Acute hemodynamic effects of intravenous nicardipine in patients treated chronically with propranolol for coronary artery disease.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Coronary Disease; Drug Therapy, Combination; Heart Rate | 1987 |
Effects of nicardipine on left ventricular function and energetics in man.
Topics: Angina Pectoris; Calcium Channel Blockers; Cardiac Output; Coronary Circulation; Coronary Disease; H | 1986 |
Myocardial ischemia during intravenous nicardipine administration.
Topics: Aged; Coronary Disease; Hemodynamics; Humans; Male; Nicardipine; Nifedipine; Oxygen Consumption; Vas | 1985 |
Immediate and long-term effects of nicardipine, at rest and during exercise, in patients with coronary artery disease.
Topics: Aged; Calcium Channel Blockers; Coronary Disease; Female; Hemodynamics; Humans; Male; Middle Aged; N | 1985 |
Effects of nicardipine on ischemic mechanical failure and tissue injury in isolated perfused rat heart.
Topics: Adenine Nucleotides; Animals; Blood Pressure; Coronary Circulation; Coronary Disease; Creatine Kinas | 1985 |